2024 AGENDA

7:30 - 8:25 AM

Check-in & Networking Breakfast

8:25 - 8:35 AM

Opening & Hot Topics in the Retina Space

Presented By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

8:35 - 9:50 AM

Innovation Showcase

Outlook Therapeutics | Russell Trenary III, President & CEO
Neurotech Pharmaceuticals | Richard Small, CEO
Stuart Therapeutics | Eric Schlumpf, President & CEO
Tarsier Pharma | Daphne Haim-Langford, PhD, CEO
Annexin Pharmaceuticals | Anders Haegerstrand, MD, PhD, CEO
Kiora Pharmaceuticals | Brian Strem, CEO
RetinAI | Carlos Ciller, CEO
RevOpsis | Ramanath Bhandari, MD, Founder, Interim CEO & Chairman
Opthea Limited | Frederic Guerard, PharmD, CEO
InGel Therapeutics | Pierre Dromel, PhD, Founder and CEO

9:50 - 10:20 AM

Navigating Challenges in Crafting Effective Clinical Trial Strategies

Panelist:

Keith Lane, MBA. Vice President & Therapeutic Area Head – Ora
Michael Singer, MD, Clinical Professor - UT Health San Antonio
Rishi P. Singh, MD, FASRS, Vice President/Chief Medical Officer - Martin Hospitals / Professor of Ophthalmology - Cleveland Clinic Lerner College of Medicine
Jonathan Weyne, VP Therapeutic Area Lead, Global Development - Regeneron

Moderated By:
Baruch Kuppermann, MD, PhD, Steinert Professor and Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute - University of California

10:20 - 10:50 AM

The Entry of Biosimilars and the Effect on the Retina Market and Innovation

Panelist:
Dilsher Dhoot, MD , Partner - California Retina Consultants
Alan J. Franklin, MD, PhD, Ophthalmologist, Vitreoretinal Diseases and Surgery
Tim de Gavre, VP, Chief Commercial Officer US - Sandoz
Andrew A. Moshfeghi, MD, MBA, Vice Chair for Clinical Affairs, Medical Director, Director: Vitreoretinal Surgery Fellowship, Associate Professor Ophthalmology - USC Roski Eye Institute - Keck School of Medicine - University of Southern California

Moderated By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

10:50 - 11:15 AM

Networking and Refreshment Break

11:15 - 12:00 PM

Spotlight on Drug Delivery

Overview Presented By:
Michael Singer, MD, Clinical Professor - UT Health San Antonio

EyePoint Pharmaceuticals | Scott Jones, Chief Commercial Officer
Ocular Therapeutix | Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
Optigo Biotherapeutics | Houman Hemmati, MD, PhD, Co-Founder & CMO
Ripple Therapeutics | Tom Reeves, Co-Founder, President & CEO
Re-Vana Therapeutics | Patrick Ruane, PhD, Chief Operating Officer

12:00 - 1:00 PM

Spotlight on Dry AMD & GA

Overview Presented By:
Andrew A. Moshfeghi, MD, MBA, Vice Chair for Clinical Affairs, Medical Director, Director: Vitreoretinal Surgery Fellowship, Associate Professor Ophthalmology - USC Roski Eye Institute - Keck School of Medicine - University of Southern California

Annexon BioSciences | Jamie Dananberg, MD, Chief Medical Officer
GelMEDIX | Max Cotler, Chief Operating Officer
ONL Therapeutics | David Esposito, CEO
Astellas Pharma | Sharon Bakalash, MD, PhD, Executive Director
Stealth BioTherapeutics | Reenie McCarthy, CEO
FELIQS | Kenichiro Kuninobu, PhD, CEO
Apellis | Beth Marsh, VP, North America Sales and Marketing

1:00 - 1:45 PM

Networking Lunch

1:45 - 2:15 PM

Future of Retina Innovation

Panelist:
Margaret Chang, MD, Senior Partner - Retinal Consultants of Sacramento
Carl D. Regillo, MD, FACS, FASRS, Chief, Retina Service - Wills Eye Hospital
Steven Schwartz, MD, Chief of the Retina Division - Jules Stein Eye Institute, UCLA
Ivo Stoilov, MD, Principal Medical Director, Medical Affairs Ophthalmology - Genentech
Nadia Waheed, MD , Professor - Tufts University School of Medicine / CMO - Beacon Therapeutics

Moderated By:
Charles Wykoff, MD, PhD - Retina Consultants of Texas, Retina Consultants of America, Houston Methodist Hospital & Blanton Eye Institute

2:15 - 3:00 PM

Spotlight on DME & DR

Overview Presented By:
Jay Stewart, MD, Professor of Ophthalmology - University of California, San Francisco

3:00 - 4:05 PM

Spotlight on Regenerative Medicine

jCyte | John Pollack, MD, Chief Medical Officer
Endogena Therapeutics | Matthias Steger, PhD, MBA, Co-Founder & CEO
Nanoscope Therapeutics | Samarendra Mohanty, PhD, Co-Founder & President - Nanoscope Therapeutics
Ray Therapeutics | Peter Francis, MD, Chief Medical & Scientific Officer
REGENXBIO | Ram Palanki, PharmD, Executive Vice President & Chief Commercial Officer

Expert Panel Discussion

Panelists:
Samarendra Mohanty, PhD, Co-Founder & President - Nanoscope Therapeutics
Peter Francis, MD, PhD, Chief Medical & Scientific Officer - Ray Therapeutics
Ram Palanki, PharmD, Executive Vice President & Chief Commercial Officer - REGENXBIO
John Pollack, MD, Chief Medical Officer - jCyte
Matthias Steger, PhD, MBA, Co-Founder & CEO - Endogena Therapeutics

Moderated By:
Mark S. Humayun, MD, PhD, Professor of Ophthalmology and Co-Director - University of Southern California Roski Eye Institute

4:05 - 4:30 PM

Afternoon Networking & Refreshment Break

4:30 - 5:00 PM

Venture Insights on Retinal Innovation

Panelists:
Anna Chen, Principal - Frazier Life Sciences
Adit Ghosh, Associate - NEA
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group
Caroline Stout, Partner - EcoR1 Capital

Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Executive Chairman - Eyconis / Senior Partner - HealthQuest Capital Management

5:00 - 5:30 PM

The View from the Street

Panelists:
Anupam Dalal, MD, Chief Investment Officer and Managing Member - Acuta Capital Partners
Andrew Gitkin, Senior Managing Director, Healthcare – Leerink Partners
Cameron Taylor, Managing Director - BofA Securities | Life Sciences

Moderated By:
Pravin U. Dugel, MD, President, CEO & Executive Chairman - Ocular Therapeutix

5:30 - 6:30 PM